Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
12/2007
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007CN101090888A 4-aminopiperidine derivatives
12/19/2007CN101090883A Substituted hydroxyethylamines
12/19/2007CN100355758C Guanidine derivatives and use thereof as neuropeptide FF receptor antagonists
12/19/2007CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
12/19/2007CN100355728C Inhibitors of dipeptidyl peptidase IV
12/18/2007US7309791 Methyl (2S)-3-{4-[(3,5-dimethylisoxazol-4-yl)methylenoxy]phenyl}-2-[(4-phenyl-1,3-thiazol-2-yl)amino]propionate; (2S)-3-{4-[(3,5-dimethylisoxazol-4-yl)methylenoxy]phenyl}-2-[(4-phenyl-1,3-thiazol-2-yl)amino]propionic acid; bind to PPAR gamma receptor and modify its activity
12/18/2007US7309715 sulfonamide-substituted N-heterocyclics including pyrroles, oxazoles, thiazoles, imidazoles and their fused analogs, e.g., 3-Chloro-N-(2-ethylsulfanylbenzothiazol-6-yl)-2-methylbenzenesulphonamide; 11 beta -hydroxysteroid dehydrogenase inhibitors
12/18/2007US7309714 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/18/2007US7309709 And oxazole sulfonamides: 3-(2-{1-[(4-Chloro-benzenesulfonyl)-(2,5-difluoro-phenyl)-amino]-ethyl}-thiazol-5-yl)-propionic acid, 4-Chloro-N-(2,5-difluoro-phenyl)-N-[1-(4-methyl-5-{[3-(2-oxo-pyrrolidin-1-yl)-propylamino]-methyl}-thiazol-2-yl)-ethyl]-benzenesulfonamide; Alzheimer's disease
12/18/2007US7309708 Serine protease inhibition via N-(distubstituted aminomethylcarbonyl)-2-[N-(1-sulfonylamido-1-cyclopropanyl)amido]pyrrolidines
12/13/2007WO2007142904A2 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands
12/13/2007WO2007141009A1 N- (l-alkyl-2- phenylethyl) -carboxamide derivatives and use thereof as fungicides
12/13/2007CA2659701A1 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands
12/13/2007CA2653520A1 N- (l-alkyl-2- phenylethyl) -carboxamide derivatives and use thereof as fungicides
12/12/2007EP1863757A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/12/2007EP1143943B1 USE OF p53 INHIBITORS FOR THE TREATMENT OF SIDE EFFECTS OF CANCER THERAPY
12/12/2007EP0932606B1 Inhibitors of prenyl transferases
12/12/2007CN101087769A Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity
12/12/2007CN101087768A Thrombopoietin activity modulating compounds and methods
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007CN101087754A Novel cyclohexane derivatives
12/12/2007CN101085761A Febuxotat microcrystal and compositions thereof
12/11/2007US7307173 E.g., 3-(2-(p-dibutylaminostyryl)thiophen-5-ylvinylene)-4-cyano-5-dicyanomethylene-2-pyrrolinone or similar thiazole derivatives; organic nonlinear optical applications
12/11/2007US7307095 Osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis, (S)-2-(Benzooxazol-2-ylamino)-3-cyclohexyl-N-[2-(5-fluoro-2,3-dihydro-indol-1-yl)-ethyl]-propionamide
12/11/2007US7307093 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof
12/11/2007US7307044 Use as insecticides, fungicides and/or herbicides; e.g. 3-(2-methyl-5-(4-chloro-phenyl)phenyl)-3-chloro-5,5-dimethyl-pyrrolidin-2,4-dione
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007WO2007140439A2 Compounds as cannabinoid receptor ligands and uses thereof
12/06/2007WO2007140233A1 Inhibitors of polo-like kinases
12/06/2007WO2007138705A1 Tumor suppressor
12/06/2007WO2007138343A1 N-phenylamidines as 5-ht2a receptor antagonists
12/06/2007WO2007138112A2 Compounds that interact with ion channels, in particular with ion channels from the kv family
12/06/2007WO2007137962A1 Thiazole derivatives
12/06/2007WO2007072143A3 Chemical compounds
12/06/2007WO2007054970A3 Novel polymorphic forms of (s)-(-)-2-amino-6-(n- propylamino) 4,5,6,7- tetrahydrobenzothiazole
12/06/2007US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
12/06/2007US20070281946 Tri(cyclo) substituted amide compounds
12/06/2007US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1
12/06/2007US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands
12/06/2007CA2652162A1 Thiazole derivatives
12/06/2007CA2651368A1 Tumor suppressor
12/06/2007CA2647598A1 Compounds as cannabinoid receptor ligands and uses thereof
12/06/2007CA2647597A1 Thiazole compounds as cannabinoid receptor ligands and uses thereof
12/06/2007CA2647592A1 Inhibitors of polo-like kinases
12/05/2007EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1861384A1 11-beta-hydroxysteroid dehydrogenase inhibitors
12/05/2007EP1861374A1 Carboxanilides as microbiocides
12/05/2007EP1861079A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists
12/05/2007EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
12/05/2007EP1658288B1 2-amino-5-benzoylthiazole npy antagonists
12/05/2007EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1169294B1 Pharmaceutical compounds
12/05/2007CN101084203A New 3-phenylpropionic acid derivatives for the treatment of diabetes
12/05/2007CN101084202A Polymer-filler coupling additives
12/05/2007CN101083982A Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
12/05/2007CN101081840A Production method of rubber vulcanization accelerator N-cyclohexyl-2-benzothiazole sulfonamide
12/05/2007CN101081839A Refining technique of famotidine raw material
12/05/2007CN100353581C Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies
12/05/2007CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/05/2007CN100352809C Aminophenylbenzothiazole compounds
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304058 For therapy of Alzheimer's disease, depression
12/04/2007US7303926 Causing necrosis or apoptosis of target tissue using both type 1 and type 2 mechanisms
12/04/2007CA2202495C Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
11/2007
11/29/2007WO2007136059A1 Composition for diagnosing amyloid-related disease
11/29/2007WO2007135080A2 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them
11/29/2007WO2007134827A1 5-phenyl-thiaz0l-2-yl-urea derivatives and use as pi3 kinase inhibitors
11/29/2007WO2007134799A1 Novel microbiocides
11/29/2007WO2007112914A3 Ceramide kinase modulation
11/29/2007WO2007092190A3 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
11/29/2007WO2007086884A3 Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use
11/29/2007US20070276144 Synthesis Of Discodermolide And Variants Thereof
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070276011 Plasminogen Activator Inhibitor-1 Inhibitor
11/29/2007US20070275988 Transition state structure and inhibitors of thymidine phosphorylases
11/29/2007US20070275980 Amide Derivatives, Process For Preparation Thereof And Use Thereof As Insecticide
11/29/2007US20070275960 Phenyl and pyridyl compounds for inflammation and immune-related uses
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007CA2652440A1 Composition for diagnosis of amyloid-related disease
11/29/2007CA2652259A1 Substituted esters as cannabinoid-1 receptor modulators
11/29/2007CA2650795A1 Novel microbiocides
11/29/2007CA2650655A1 5-phenyl-thiaz0l-2-yl-urea derivatives and use as pi3 kinase inhibitors
11/29/2007CA2649794A1 (2r)-2-[(4-sulfonyl)aminophenyl] propanamides and pharmaceutical compositions containing them
11/28/2007EP1859798A1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
11/28/2007EP1858901A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/28/2007EP1858845A2 Novel tyrosine derivatives
11/28/2007EP1858525A2 Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use
11/28/2007EP1399430B1 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor
11/28/2007CN101080389A Indane amides with antiproliferative activity
11/28/2007CN100351237C Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
11/28/2007CN100351234C Bis-heterocyclic compounds with antitumour and chemosensitising activity
11/27/2007US7301028 Mitotic kinesin inhibitors
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007US7300928 Benzimidazolidinone derivatives as muscarinic agents
11/22/2007WO2007132546A1 Pharmaceutical containing thiazole derivative as active ingredient
11/22/2007WO2007105989A3 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
11/22/2007WO2007081091A8 Rhodandse derivarives, a process for the preparation thereof and pharmaceutical composition containing the same
11/22/2007WO2007062314A3 Heterocyclic cetp inhibitors
11/22/2007US20070270476 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 337